Health Canada Approval

Psilocybin API Import From US To Canada Approved: Here's What You Need To Know
Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
This Psychedelic-Assisted Therapy Study Offers Therapists Experience With Magic Mushroom Tea
Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce

Health Canada Approval Recent News

Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial
Psychedelics biotechs Nova Mentis Life Science Corp. (OTCQB: NMLSF) and Wellbeing Digital Sciences Inc. (OTC: KONEF)’s subsidiary KGK Sciences Inc.
New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details
Canadian-based psychedelics company Nova Mentis Life Science Corp.
Merck Secures Canadian Regulatory Nod For KEYTRUDA In Skin Cancer After Resection
Health Canada has granted approval for Merck’s (NYSE: MRK) KEYTRUDA (pembrolizumab) for the adjuvant treatment of adult and pediatric (12 years and older) patients with stage IIB or IIC melanoma following complete resection. 
Bristol Myers Squibb Secures Canadian Regulatory Nod For Lung Cancer Candidate In Neoadjuvant Setting
Health Canada announced approval for Bristol Myers Squibb’s (NASDAQ: BMY) OPDIVO (nivolumab) 360 mg (injection for intravenous use) in combination with platinum-doublet chemotherapy every three weeks for three cycles in adult patients with resectable non-small cell lung cancer (NSCLC) in the neoadjuvant setti